Population pharmacokinetics of clinafloxacin in healthy volunteers and patients with infections: experience with heterogeneous pharmacokinetic data. (vol 40, pg 307, 2001)

被引：0
|
作者：
Frame, B
Koup, J
Miller, R
Lolonde, R
机构：
来源：
CLINICAL PHARMACOKINETICS | 2001年 / 40卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：537 / 537
页数：1
相关论文
共 17 条
  • [1] Population pharmacokinetics of clinafloxacin in healthy volunteers and patients with infections - Experience with heterogeneous pharmacokinetic data
    Frame, B
    Koup, J
    Miller, R
    Lalonde, R
    CLINICAL PHARMACOKINETICS, 2001, 40 (04) : 307 - 315
  • [2] Population Pharmacokinetics of Clinafloxacin in Healthy Volunteers and Patients with InfectionsExperience with Heterogeneous Pharmacokinetic Data
    Bill Frame
    Jeffrey Koup
    Raymond Miller
    Richard Lalonde
    Clinical Pharmacokinetics, 2001, 40 : 307 - 315
  • [3] Population Pharmacokinetics of Finafloxacin in Healthy Volunteers and Patients with Complicated Urinary Tract Infections
    Taubert, Max
    Lueckermann, Mark
    Vente, Andreas
    Dalhoff, Axel
    Fuhr, Uwe
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [4] Population Pharmacokinetic Analysis for Imipenem-Relebactam in Healthy Volunteers and Patients With Bacterial Infections
    Bhagunde, Pratik
    Patel, Parul
    Lala, Mallika
    Watson, Kenny
    Copalu, William
    Xu, Ming
    Kulkarni, Pooja
    Young, Katherine
    Rizk, Matthew L.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (10): : 748 - 758
  • [5] Population pharmacokinetics of finafloxacin in healthy volunteers and patients suffering from urinary tract infections
    Taubert, M.
    Lueckermann, M.
    Fuhr, U.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2017, 390 : S16 - S16
  • [6] The Influence of Sparse Data Sampling on Population Pharmacokinetics: A Post Hoc Analysis of a Pharmacokinetic Study of Morphine in Healthy Volunteers
    Ariano, Robert E.
    Duke, Peter C.
    Sitar, Daniel S.
    CLINICAL THERAPEUTICS, 2012, 34 (03) : 668 - 676
  • [7] Population Pharmacokinetics of Ceftolozane/Tazobactam in Healthy Volunteers, Subjects With Varying Degrees of Renal Function and Patients With Bacterial Infections
    Chandorkar, Gurudatt
    Xiao, Alan
    Mouksassi, Mohamad-Samer
    Hershberger, Ellie
    Krishna, Gopal
    JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 55 (02): : 230 - 239
  • [8] Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease (vol 116, pg 1052, 2024)
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (01) : 309 - 309
  • [9] Hospitalized Patients With and Without Hemodialysis Have Markedly Different Vancomycin Pharmacokinetics: A Population Pharmacokinetic Model-Based Analysis (vol 40, pg 212, 2018)
    Goti, V
    Chaturvedula, A.
    Fossler, M. J.
    THERAPEUTIC DRUG MONITORING, 2019, 41 (04) : 549 - 549
  • [10] Population Pharmacokinetic/Pharmacodynamic Modeling of Dazodalibep, a CD40L Antagonist, in Healthy Volunteers and Patients with Rheumatoid Arthritis and Sjogren's Syndrome
    Der, Kenneth
    Crass, Ryan
    Smith, Brendan
    Byon, Wonkyung
    Xin, Yan
    Huang, Jiayin
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2706 - 2706
12